• The market is benefiting from the growing adoption of minimally invasive aneurysm repair, as endovascular procedures offer shorter recovery times and reduced surgical risks compared to open repair methods.

• Rising prevalence of aortic aneurysms driven by an ageing population and risk factors such as hypertension, smoking, and cardiovascular disease continues to propel demand for these devices.

• The stent-graft systems segment remains dominant, reflecting its role as the standard of care in modern endovascular repair procedures.

• Advancements in fenestrated and branched stent-grafts enable treatment of complex anatomies, opening opportunities for innovation and expansion into previously untreatable cases.

• Challenges persist due to high procedural costs, limited access to specialized infrastructure, and reimbursement constraints in certain healthcare systems.

• North America leads in adoption due to robust healthcare infrastructure, while Asia-Pacific is emerging rapidly with growing investment in vascular care and screening programs.

• Key players are emphasizing patient-specific solutions, expanding treatment indications, and improving postoperative monitoring to strengthen their competitive positioning.

In this report, the Endovascular Aneurysm Repair Devices Market has been segmented by Indication, Site, Anatomy, Products and Geography.

Endovascular Aneurysm Repair Devices Market, Segmentation by Indication

The Endovascular Aneurysm Repair Devices Market has been segmented by Indication into Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Ascending Aortic Aneurysm, Descending Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, Thoracic Arch Aortic Aneurysm and Others.

Abdominal Aortic Aneurysm

Abdominal Aortic Aneurysm (AAA) is the most common indication for endovascular aneurysm repair, accounting for nearly 65% of cases globally. This condition involves a localized enlargement of the abdominal aorta, which poses significant rupture risk if untreated. Advances in minimally invasive devices have led to improved patient outcomes and shorter hospital stays for AAA repair.

Thoracic Aortic Aneurysm

Thoracic Aortic Aneurysm (TAA) affects the portion of the aorta within the chest cavity and represents about 20% of endovascular aneurysm repair procedures. TAAs are often asymptomatic but can lead to life-threatening complications if the aneurysm expands. Device innovations are focused on conformability and durability to address the complex anatomy of the thoracic aorta.

Ascending Aortic Aneurysm

Ascending Aortic Aneurysms make up approximately 5% of the market share within endovascular repair indications. These aneurysms occur in the section of the aorta rising from the heart and require precise device placement due to proximity to the aortic valve and coronary arteries. The evolving technology aims to minimize procedural risks in this challenging area.

Descending Aortic Aneurysm

Descending Aortic Aneurysms account for around 8% of cases treated with endovascular devices. Located in the descending portion of the thoracic aorta, these aneurysms benefit from less invasive repair techniques that reduce patient morbidity compared to open surgery. Device flexibility and sealing effectiveness are key design factors for this segment.

Thoracoabdominal Aortic Aneurysm

Thoracoabdominal Aortic Aneurysms (TAAA) are less common but complex, representing about 2% of the endovascular aneurysm repair market. These aneurysms span both thoracic and abdominal regions, requiring highly specialized devices to manage the extended affected area while preserving blood flow to vital organs.

Thoracic Arch Aortic Aneurysm

Thoracic Arch Aortic Aneurysms, comprising about 1% of the market, are challenging due to the arch's curved anatomy and branching vessels. Recent device advancements include branched and fenestrated stent grafts designed to maintain perfusion to the head and upper extremities while excluding the aneurysm.

Others

The 'Others' category, making up roughly 1-2% of the market, includes rare and atypical aneurysm locations that require customized endovascular solutions. Ongoing innovation focuses on expanding device adaptability to cover these less frequent but critical cases.

Endovascular Aneurysm Repair Devices Market, Segmentation by Site

The Endovascular Aneurysm Repair Devices Market has been segmented by Site into Infrarenal, Pararenal, Juxtarenal and Suprarenal.

Infrarenal

The Infrarenal site is the most frequently treated location in endovascular aneurysm repair, accounting for approximately 70% of procedures. This site is located below the renal arteries, making device placement more straightforward with lower risk. The majority of standard EVAR devices are designed specifically for infrarenal aneurysms, driving strong market demand.

Pararenal

Pararenal aneurysms, situated adjacent to the renal arteries, represent about 15% of the cases in the market. Treatment at this site is more complex due to the proximity to vital renal vessels, necessitating specialized fenestrated or branched stent grafts to ensure continued kidney perfusion.

Juxtarenal

Juxtarenal aneurysms occur close to the renal arteries but do not involve them directly, making up roughly 10% of endovascular repairs. Devices used here require precise customization to seal near the renal artery origins while maintaining adequate blood flow, demanding higher technical expertise and innovative designs.

Suprarenal

Suprarenal aneurysms are the least common, constituting around 5% of the repair procedures. Located above the renal arteries, these aneurysms require advanced endovascular devices with complex branching to protect renal and visceral arteries during repair, representing a niche but growing segment.

Endovascular Aneurysm Repair Devices Market, Segmentation by Anatomy

The Endovascular Aneurysm Repair Devices Market has been segmented by Anatomy into Traditional and Complex.

Traditional

Traditional anatomy cases make up the majority of the endovascular aneurysm repair devices market, representing approximately 75% of procedures. These aneurysms typically have favorable anatomical features such as adequate landing zones and straightforward vessel geometry, allowing the use of standard EVAR devices with high success rates and fewer complications.

Complex

Complex anatomy accounts for around 25% of endovascular aneurysm repair cases and involves challenging vascular structures such as short or angulated necks, involvement of branch vessels, or tortuous arteries. Treating complex aneurysms requires advanced device technologies including fenestrated, branched, or customized grafts, increasing procedural complexity but expanding treatment options for high-risk patients.

Endovascular Aneurysm Repair Devices Market, Segmentation by Products

The Endovascular Aneurysm Repair Devices Market has been segmented by Products into Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Grafts and Others.

Percutaneous EVAR

Percutaneous EVAR represents the largest product segment, accounting for about 50% of the market. This minimally invasive procedure involves accessing the aneurysm through small punctures in the skin, leading to reduced recovery times and fewer complications. Increasing adoption of percutaneous techniques is driving growth in this segment.

Fenestrated EVAR

Fenestrated EVAR devices make up approximately 25% of the market and are designed for complex aneurysms near branch vessels. These devices feature custom openings (fenestrations) to preserve blood flow to critical arteries, enabling treatment of anatomically challenging aneurysms that were previously inoperable with standard EVAR.

Aortic Stents & TAA Grafts

Aortic stents and Thoracic Aortic Aneurysm (TAA) grafts comprise around 20% of the market. These specialized devices focus on repairing aneurysms in the thoracic aorta, with advancements improving flexibility, sealing, and durability to accommodate the dynamic thoracic environment.

Others

The ‘Others’ category, representing about 5% of the market, includes various specialized devices and accessories supporting aneurysm repair. This segment continues to expand with innovations targeting niche applications and enhanced procedural support.

Endovascular Aneurysm Repair Devices Market, Segmentation by End User

The Endovascular Aneurysm Repair Devices Market has been segmented by Hospitals and Ambulatory Surgical Centers (ASCs)

Hospitals

Hospitals remain the primary setting for endovascular aneurysm repair procedures, accounting for around 80% of the market share. Their advanced infrastructure, comprehensive care capabilities, and availability of specialized surgical teams make them ideal for managing complex cases and emergencies. The hospital segment continues to dominate due to higher patient volumes and extensive postoperative support.

Ambulatory Surgical Centers (ASCs)

Ambulatory Surgical Centers are gaining traction, representing approximately 20% of the market. ASCs offer a cost-effective and convenient alternative for less complex aneurysm repairs, emphasizing outpatient care and faster patient turnover. Growing investments and technological advancements are enabling ASCs to expand their role in the endovascular aneurysm repair market.

Endovascular Aneurysm Repair Devices Market, Segmentation by Geography

In this report, the Endovascular Aneurysm Repair Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Endovascular Aneurysm Repair Devices Market Share (%), by Geographical Region

North America

North America holds the largest share of the endovascular aneurysm repair devices market, accounting for approximately 40% of global revenue. The region benefits from advanced healthcare infrastructure, high adoption of innovative technologies, and increasing prevalence of aortic aneurysms. Strong reimbursement policies and well-established healthcare systems drive market growth in this area.

Europe

Europe represents around 30% of the market, driven by rising awareness about minimally invasive treatments and growing elderly populations. Countries like Germany, France, and the UK are leading markets due to robust healthcare frameworks and increased access to endovascular repair devices.

Asia Pacific

Asia Pacific is a rapidly growing market, contributing about 20% to the global revenue. Expansion is fueled by increasing healthcare investments, rising prevalence of cardiovascular diseases, and improving medical infrastructure in countries such as China, India, and Japan. The region shows significant potential due to its large patient base.

Middle East and Africa

Middle East and Africa account for roughly 5% of the market share. Although still emerging, this region is witnessing growing demand for advanced medical technologies and increasing government focus on healthcare modernization, which is expected to drive market growth.

Latin America

Latin America holds around 5% of the market, with Brazil and Mexico being key contributors. Market growth is supported by increasing healthcare spending, awareness programs, and expanding hospital infrastructure focused on minimally invasive aneurysm treatments.

This report provides an in depth analysis of various factors that impact the dynamics of Endovascular Aneurysm Repair Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Aging population
• Technological advancements
• Increasing prevalence of aneurysms

• Growing demand for minimally invasive procedures - The endovascular aneurysm repair (EVAR) devices market is experiencing significant growth, primarily fueled by the rising demand for minimally invasive procedures. Minimally invasive techniques offer numerous advantages over traditional open surgeries, including shorter recovery times, reduced risk of complications, and smaller incisions, leading to less postoperative pain. As a result, patients are increasingly opting for these procedures, driving the market for EVAR devices.

  Technological advancements in endovascular techniques have enhanced the safety and efficacy of EVAR procedures, further boosting their adoption. Innovations such as improved stent graft designs, advanced imaging technologies, and better catheterization techniques have contributed to better outcomes and expanded the pool of eligible patients for endovascular treatment. Additionally, the aging population worldwide, coupled with the increasing prevalence of aneurysms, has spurred the demand for minimally invasive solutions, as these patients often seek treatments that offer quicker recovery and shorter hospital stays.

  The growing awareness among healthcare professionals and patients about the benefits of EVAR procedures has also played a pivotal role in driving market growth. Physicians are increasingly recommending endovascular interventions as a preferred treatment option for aortic aneurysms, given their lower procedural risks and better patient outcomes compared to open surgeries. Additionally, patient education initiatives and promotional activities by key market players have contributed to increased awareness about the availability and benefits of EVAR devices, further stimulating market demand.

Restraints:

• High cost of devices
• Stringent regulatory requirements
• Lack of skilled professionals

• Limited reimbursement policies - The market for endovascular aneurysm repair devices has experienced significant growth over the past decade, driven by advancements in technology, increasing prevalence of aneurysms, and rising demand for minimally invasive treatment options. Endovascular aneurysm repair (EVAR) procedures involve the placement of stent grafts inside the aorta to reinforce weak areas prone to aneurysm formation, thereby reducing the risk of rupture. These procedures offer several advantages over traditional open surgery, including shorter recovery times, reduced hospital stays, and lower complication rates.

  Despite the growth opportunities, the market faces challenges, one of which is limited reimbursement policies. Reimbursement policies play a crucial role in determining the adoption rate of EVAR procedures, as they influence both patient and physician decision-making. In many regions, reimbursement for EVAR procedures may be limited or subject to stringent criteria, making it difficult for patients to access these treatments, particularly in underinsured or low-income populations. Additionally, varying reimbursement policies across different healthcare systems and payers can create uncertainty for manufacturers and providers, impacting investment decisions and market expansion strategies.

  The limited reimbursement landscape poses a barrier to the widespread adoption of endovascular aneurysm repair devices, hindering market growth potential. Manufacturers may face challenges in achieving adequate pricing for their products, especially in regions where reimbursement rates are low or insufficient to cover the costs associated with device development, regulatory compliance, and post-market surveillance. Furthermore, healthcare providers may be reluctant to offer EVAR procedures if reimbursement rates do not adequately compensate for their time and resources, further limiting patient access to these life-saving treatments.

Opportunities:

• Emerging markets
• Development of novel devices
• Collaborations and partnerships

• Rising healthcare expenditure - The endovascular aneurysm repair (EVAR) devices market is witnessing significant growth, driven primarily by rising healthcare expenditure worldwide. As healthcare systems allocate more resources to advanced treatments and technologies, the demand for minimally invasive procedures like EVAR is on the rise. EVAR offers several advantages over traditional surgical methods for treating aortic aneurysms, including shorter recovery times, reduced risk of complications, and lower overall healthcare costs. This has led to increased adoption by both healthcare providers and patients, fueling the expansion of the EVAR devices market.

  The aging population in many regions is contributing to the growing prevalence of aortic aneurysms, further boosting the demand for EVAR devices. With advancing age, individuals are more prone to developing aneurysms, necessitating effective treatment options. EVAR procedures provide a less invasive alternative to open surgery, particularly suitable for elderly patients or those with additional health complications. As a result, the market for EVAR devices is poised for continuous growth as the population continues to age.

  Technological advancements in EVAR devices are driving market expansion. Manufacturers are constantly innovating to improve the design, materials, and functionality of these devices, enhancing their safety and efficacy. Advanced imaging techniques, such as 3D imaging and virtual reality, are also being integrated into EVAR procedures to enhance precision and outcomes. These innovations not only make EVAR procedures more effective but also contribute to overall market growth by attracting both patients and healthcare providers seeking state-of-the-art treatment options.

Endovascular Aneurysm Repair Devices Market is characterized by increasing competition where major players emphasize strategies such as partnerships and acquisitions to strengthen their position. With more than 40% of the market share held by leading companies, the focus on innovation, advanced treatment solutions, and collaboration across healthcare providers continues to shape the competitive environment.

Market Structure and Concentration
The market shows a moderate to high level of concentration, as a few established players capture over 55% of total revenues. Continuous merger activities and strategic alliances enable companies to maintain influence and drive growth. The balance between established leaders and emerging entrants adds competitive intensity and ensures steady technological advancements.

Brand and Channel Strategies
Firms prioritize strong brand positioning and expand distribution networks to enhance reach, with more than 60% of sales driven through hospital-based channels. Effective strategies in physician engagement, digital presence, and partnerships with healthcare institutions play a critical role in shaping competitive performance. Continuous collaboration strengthens credibility and market penetration.

Innovation Drivers and Technological Advancements
Nearly 70% of market competition is influenced by technological advancements, including minimally invasive devices and real-time imaging integration. Companies invest heavily in R&D to accelerate innovation and clinical effectiveness. Strategic collaboration with research institutions and healthcare providers highlights the growing importance of adaptive design and supports sustainable growth.

Regional Momentum and Expansion
Around 50% of growth is attributed to expansion in emerging regions where demand for advanced vascular repair is accelerating. Firms adapt localized strategies through regional partnerships and distribution agreements to capture rising adoption rates. Market players also enhance presence through tailored clinical education programs, supporting competitive differentiation across regional segments.

Future Outlook
The competitive outlook suggests that over 65% of companies plan to prioritize innovation and collaboration as primary strategies for long-term success. Investments in personalized treatment approaches and next-generation repair systems are set to strengthen growth. With continued technological advancements and regional expansion, competition is expected to remain dynamic, fostering progressive developments in the sector.

Key players in Endovascular Aneurysm Repair Devices Market include:

• Medtronic plc
• Cook Medical
• W. L. Gore
• Bolton Medical Inc.
• JOTEC GmbH
• Lombard Medical, Inc.
• Cardinal Health
• Endologix, Inc.
• Abbott Laboratories
• Getinge AB
• Terumo
• Johnson
• Braun Melsungen
• Stryker
• Atrium Medical

In this report, the profile of each market player provides following information:

• Market Share Analysis
• Company Overview and Product Portfolio
• Key Developments
• Strategies
• Financial Overview
• Company SWOT Analysis